SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001104659-16-163802
Filing Date
2016-12-23
Accepted
2016-12-23 18:01:39
Documents
1
Period of Report
2016-10-18

Document Format Files

Seq Description Document Type Size
1 3/A a3a.html 3/A  
1 3/A a3a.xml 3/A 24203
  Complete submission text file 0001104659-16-163802.txt   25534
Mailing Address ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA 94104
Business Address
Bolzon Bradley J PhD (Reporting) CIK: 0001354345 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-37923 | Film No.: 162069508

Mailing Address AESCHENVORSTADT 36 BASEL V8 4051
Business Address AESCHENVORSTADT 36 BASEL V8 4051 6173154600
CRISPR Therapeutics AG (Issuer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)